FI50116B - - Google Patents

Info

Publication number
FI50116B
FI50116B FI1234/69A FI123469A FI50116B FI 50116 B FI50116 B FI 50116B FI 1234/69 A FI1234/69 A FI 1234/69A FI 123469 A FI123469 A FI 123469A FI 50116 B FI50116 B FI 50116B
Authority
FI
Finland
Application number
FI1234/69A
Other languages
Finnish (fi)
Other versions
FI50116C (fi
Inventor
Hermann Bretschneider
Kraft Hohenlohe-Oehringen
Klaus Grassmayr
Andre Gruessner
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of FI50116B publication Critical patent/FI50116B/fi
Publication of FI50116C publication Critical patent/FI50116C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/64Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/52Y being a hetero atom
    • C07C311/54Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI691234A 1968-04-26 1969-04-25 Menetelmä veren sokeripitoisuutta alentavan sulfonyylivirtsa-ainejohda nnaisen valmistamiseksi. FI50116C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH628568A CH505069A (de) 1968-04-26 1968-04-26 Verfahren zur Herstellung von Sulfonylharnstoffderivaten

Publications (2)

Publication Number Publication Date
FI50116B true FI50116B (es) 1975-09-01
FI50116C FI50116C (fi) 1975-12-10

Family

ID=4307138

Family Applications (1)

Application Number Title Priority Date Filing Date
FI691234A FI50116C (fi) 1968-04-26 1969-04-25 Menetelmä veren sokeripitoisuutta alentavan sulfonyylivirtsa-ainejohda nnaisen valmistamiseksi.

Country Status (16)

Country Link
US (1) US3654357A (es)
JP (2) JPS4927181B1 (es)
AT (3) AT288423B (es)
BE (1) BE732068A (es)
CA (1) CA949588A (es)
CH (4) CH505069A (es)
DE (1) DE1921287A1 (es)
ES (1) ES366465A1 (es)
FI (1) FI50116C (es)
FR (1) FR2035800B1 (es)
GB (2) GB1222179A (es)
IE (1) IE33065B1 (es)
IL (1) IL31972A0 (es)
NL (1) NL6906018A (es)
SE (2) SE373841B (es)
YU (1) YU34398B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3818027A (en) * 1968-04-26 1974-06-18 Hoffmann La Roche Processes and intermediates for sulfonylurea derivatives
BE791449A (fr) * 1971-11-17 1973-05-16 Roussel Uclaf Nouvelles urees substituees et procede de
US8268352B2 (en) * 2002-08-05 2012-09-18 Torrent Pharmaceuticals Limited Modified release composition for highly soluble drugs
US8216609B2 (en) * 2002-08-05 2012-07-10 Torrent Pharmaceuticals Limited Modified release composition of highly soluble drugs
CN104163864B (zh) 2007-03-30 2017-08-01 Ambrx公司 经修饰fgf‑21多肽和其用途
PL3412302T3 (pl) 2014-10-24 2021-11-02 Bristol-Myers Squibb Company Zmodyfikowane polipeptydy fgf-21 i ich zastosowania

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL131473C (es) * 1966-10-28
GB1164376A (en) * 1967-02-15 1969-09-17 Science Union & Cie New Oxobicyclic Derivatives and Process for Preparing Them

Also Published As

Publication number Publication date
YU80969A (en) 1978-12-31
GB1222179A (en) 1971-02-10
SE373841B (es) 1975-02-17
AT288420B (de) 1971-03-10
IE33065L (en) 1969-10-26
IL31972A0 (en) 1969-06-25
BE732068A (es) 1969-10-27
CH505069A (de) 1971-03-31
JPS4927181B1 (es) 1974-07-16
FI50116C (fi) 1975-12-10
NL6906018A (es) 1969-10-28
CA949588A (en) 1974-06-18
AT288422B (de) 1971-03-10
JPS4927180B1 (es) 1974-07-16
CH505073A (de) 1971-03-31
IE33065B1 (en) 1974-03-06
CH505071A (de) 1971-03-31
GB1222180A (en) 1971-02-10
AT288423B (de) 1971-03-10
FR2035800B1 (es) 1973-07-13
YU34398B (en) 1979-07-10
SE399883B (sv) 1978-03-06
CH505072A (de) 1971-03-31
DE1921287A1 (de) 1970-11-19
ES366465A1 (es) 1971-03-16
US3654357A (en) 1972-04-04
FR2035800A1 (es) 1970-12-24

Similar Documents

Publication Publication Date Title
AU1946070A (es)
AU428130B2 (es)
AU2374870A (es)
FR2035800B1 (es)
AU429879B2 (es)
AU416157B2 (es)
AU2581067A (es)
AU421558B1 (es)
AU2580267A (es)
AR203075Q (es)
AU3224368A (es)
AU3789668A (es)
AU4270368A (es)
BE727403A (es)
AU3083868A (es)
BE709435A (es)
BE709415A (es)
BE728750A (es)
AU2496167A (es)
BE728558A (es)
BE728372A (es)
BE728100A (es)
BE728071A (es)
BE727710A (es)
AU4224469A (es)